New insight in staphylococcin research: Bacteriocin and/or bacteriocin-like inhibitory substance(s) produced by S. aureus AB188

World Journal of Microbiology and Biotechnology

Volumn 22, Issue 7, 2006, Pages 713-722

  Saeed, Sadia ^a   Rasool, Sheikh Ajaz ^a   Ahmed, Samia ^a   Khanum, Tanweer ^b   Khan, Muhammad Bashir ^a   Abbasi, Atiya ^a   Ali, Syed Abid ^a,c  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b JINNAH UNIVERSITY FOR WOMEN   (Pakistan)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Bacteriocins; Dermatophytes; Staphylococcin; Tuberculosis

Indexed keywords

BIOTECHNOLOGY; DISEASES; ESCHERICHIA COLI; FUNGI; MICROBIOLOGY;

BACTERIOCINS; DERMATOPHYTES; STAPHYLOCOCCIN; TUBERCULOSIS;

BACTERIA;

ARTHRODERMA BENHAMIAE; ARTHRODERMA GYPSEUM; ARTHRODERMATACEAE; BACILLUS SUBTILIS; ESCHERICHIA COLI; MICROSPORUM CANIS; MYCOBACTERIUM TUBERCULOSIS; NEGIBACTERIA; POSIBACTERIA; SALMONELLA TYPHI; SHIGELLA DYSENTERIAE; STAPHYLOCOCCUS AUREUS; TRICHOPHYTON; TRICHOPHYTON RUBRUM;

EID: 33745725966     PISSN: 09593993     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11274-005-9095-z     Document Type: Article

References (36)

1. Bhunia, A.K., Johnson, M.C. & Ray, B. 1988 Purification, characterization and antimicrobial spectrum of bacteriocin produced by Pediococcus acidilaciti. Journal of Applied Bacteriology 65, 261-268.
2. Chen, H. & Hoover, D.G. 2003 Bacteriocins and their food applications. Comprehensive Reviews in Food Science, Food and Safety 2, 82-100.
3. Cleveland, J., Montville, T.J., Nes, I.F. & Chikindas, M.L. 2001 Bacteriocins: safe, natural antimicrobials for food preservation. International Journal of Food Microbiology 71, 1-20.
4. Cotter, P.D., Hill, C. & Ross, R.P. 2005 Bacterial lantibiotics: strategies to improve therapeutic potential. Current Protein and Peptide Sciences 6, 61-75.
5. Crupper, S.S, Gies, A.J. & Iandolo, J.J. 1997 Purification and characterization of staphylococcin bacR1, a broad-spectrum bacteriocin. Applied and Environmental Microbiology 63, 4185-4190.
6. Culliton, B.J. 1992 Drug-resistant tuberculosis may bring epidemic (Nature London) 356, 472-490.
7. Daw, M.A. & Falkiner, F.R. 1996 Bacteriocins: nature, function and structure. Micron 27, 467-479.
8. Diep, D.B. & Nes, I.F. 2002 Ribosomally synthesized antibacterial peptides in Gram-positive bacteria. Current Drug Targets 3, 107-122.
9. Dye, C., Scheele, S., Dolin, P. & Pathania, V. 1999 Global burden of tuberculosis, estimated incidence, prevalence and mortality by country. Journal of the American Medical Association 282, 677-686.
10. Eijsink, V.G.H., Axelsson, L., Diep, D.B., Havarstein, L.S., Holo, H. & Nes, I.F. 2002 Production of class II bacteriocins by lactic acid bacteria; an example of biological warfare and communication. Antonie Van Leenwenhoek 81, 639-654.
11. Ennahar, S., Sashihara, T., Sonomoto, K. & Ishizaki, A. 2000 Class IIa bacteriocins: biosynthesis, structure and activity. FEMS Microbiology Reviews 24, 85-106.
12. Fitzgerald, R.J., Morhart, R.E., Marquez, C. & Adams, B.O. 1986 Inhibition of caries in hamsters treated with staphylococcin 1580 . Infection and Immunity 54, 288-290.
13. Franz, C.M.A.P., Holzapfel, W.H. & Stiles, M.E. 1999 Enterococci at the cross-roads of food safety?. International Journal of Food Microbiology 47, 1-24.
14. Furmanek, B., Kaczorowski, T., Bugalski, R., Bielawski, K., Bogdanowicz, J. & Podhajska, A.J. 1999 Identification, characterization and purification of the lantibiotic staphylococcin T, a natural gallidermin variant. Journal of Applied Microbiology 87, 856-866.
15. Hanlin, M.B., Kalchayanand, N., Ray, P. & Ray, B. 1993 Bacteriocins of lactic acid bacteria in combination have greater antibacterial activity. Journal of Food Protection 56, 252-255.
16. Jack, R.W., Tagg, J.R. & Ray, B. 1995 Bacteriocins of Gram-positive bacteria. Microbiological Review 59, 171-200.
17. Joerger, R.D. 2003 Alternatives to antibiotics: bacteriocins, antimicrobial peptides and bacteriophages. Poultry Science 82, 640-647.
18. Kariba, R.M., Siboe, G.M. & Dossagi, S.F. 2001 In vitro antifungal activity of Schizozygia coffaeoides bail (apocynaceae) extracts. Journal of Ethnopharmacology 74, 41-44.
19. Kruszewska, D., Sahl, H.-G., Bierbaum, G., Pag, U., Hynes, S.O. & Ljungh, Å. 2004 Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. Journal of Antimicrobial Chemotherapy 54, 648-653.
20. Magnusson, J. & Schnürer, J. 2001 Lactobacillus coryniformis subsp. Coryniformis strain Si3 produces a broad-spectrum proteinaceous antifungal compound. Applied and Environmental Microbiology 67, 1-5.
21. Marks, J. 1974 The culture and identification of mycobacteria. In Public Health Laboratory Service Monograph, No. 5 Laboratory Methods, eds. Willis A.T. & Collins C.H. London.
22. Muriana, P.M. & Klaenhammer, T.R. 1991 Cloning, phenotypic expression, and DNA sequence of the gene for lactacin F, an antimicrobial peptide produced by lactobacillus spp. Journal of Bacteriology 173, 1779-88.
23. Navaratna, M.A.D.B., Sahl, H.-G. & Tagg, J.R. 1998 Two component anti- Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Applied and Environmental Microbiology 64, 4803-4808.
24. Navaratna, M.A.D.B., Sahl, H.-G. & Tagg, J.R. 1999 Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus C55 and other phage group II S. aureus strains and demonstration of an association with the exfoliative toxin B gene. Infection and Immunity 67, 4268-4271.
25. Netz, D.J.A., Sahl, H.-G., Marcolino, R., Nascimento, J.D.S., de Oliveira, S.S., Soares, M.B. & de Freire Bastos, M.D.C. 2001 Molecular characterization of aureocin A70, a multi-peptide bacteriocin isolated from Staphylococcus aureus. Journal of Molecular Biology 311, 939-949.
26. Pag, U. & Sahl, H.-G. 2002 Multiple activities in lantibiotics-models for the design of novel antibiotics. Current Pharmacological Design 8, 815-833.
27. Parrot, M., Charest, M. & Lavoie, M.C. 1989 Production of mutacin-like substances by Streptococcus mutans. Canadian Journal of Microbiology 35, 366-372.
28. Perruci, S., Mancianti, F., Cioni, P.L., Flamini, G., Morelli, I. & Macchioni, G. 1993 In vitro antifungal activity of essential oils against some isolates of Microsporum canis and Microsporum gypseum. Planta Medica 60, 184-187.
29. Riley, M.A. & Wertz, J.E. 2002 Bacteriocins: evolution, ecology, and application. Annual Review of Microbiology 56, 117-137.
30. Ross, R.P., Galvin, M., McAuliffe, O., Morgan, S.M., Ryan, M.P., Twomey, D.P., Meaney, W.J. & Hill, C. 1999 Developing applications for lactococcal bacteriocins. Antonie van Leeuwenhoek 76, 337-346.
31. Sahl, H.-G. 1994 Staphylococcin 1580 is identical to the lantibiotic epidermin: implications for the nature of bacteriocins from Gram-positive bacteria. Applied and Environmental Microbiology 60, 752-755.
32. Sahl, H.-G. & Bierbaum, G. 1998 Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from Gram-positive bacteria. Annual Reviews of Microbiology 52, 41-79.
33. Schillinger, U. & Lucke, F.K. 1989 Antibacterial activity of Lactobacillus sake isolated from meat. Applied and Environmental Microbiology 55, 1901-1906.
34. Shinefield, H.R., Ribble, J.C. & Boris, M. 1971 Bacterial interference between strains of Staphylococcus aureus. American Journal of Disable Children 121, 148-152.
35. Ungermann, V., Goeke, K., Feidler, H.P. & Zahner, H. 1991 Optimization of fermentation of gallidermin and epidermin. In Nisin and Novel Lantibiotics, eds. Jung G. & Sahl H.G. pp. 410-421, Leiden: Escom Publisher. ISBN 9072199111.
36. Yamane, N., Chilima, B.Z., Tosaka, M., Okazawa, Y. & Tanno, K. 1996 Determination of antimycobacterial activities of fluoroquinolones against clinical isolates of Mycobacterium tuberculosis: comparative determination with egg based Ogawa and agar based Middlebrook 7H10 media. Kekkaku 71, 453-458.